Healthcare -
Biotechnology - NASDAQ - US
$ 0.1538
-1.91 %
$ 6.11 M
Market Cap
-0.14
P/E
VIRX - OPERATING EXPENSES
Operating Expenses VIRX - Viracta Therapeutics, Inc.
50.7 M
LAST VALUE
40.18%
2 YEAR CAGR
14.34%
5 YEAR CAGR
2.47%
10 YEAR CAGR